The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema

Rein Posthuma; Lowie E G W Vanfleteren

doi:10.1183/20734735.0004-2020

The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema

Breathe (Sheff). 2020 Mar;16(1):200004. doi: 10.1183/20734735.0004-2020.

Authors

Rein Posthuma^{1

2

3}, Lowie E G W Vanfleteren^{1

2

4}

Affiliations

¹ CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands.
² Dept of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
³ NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
⁴ COPD Centre, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

Abstract

The STELVIO trial was crucial to ensure that bronchoscopic lung volume reduction using one-way valves has evolved from an experimental intervention into a state-of-the-art treatment option for specific patients with advanced emphysema http://bit.ly/2IgMrsp.